Mydecine Innovations Group (STU:0NF0) Operating Cash Flow per Share : €-0.23 (TTM As of Sep. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Mydecine Innovations Group Operating Cash Flow per Share?

Mydecine Innovations Group's operating cash flow per share for the three months ended in Sep. 2023 was €-0.00. Mydecine Innovations Group's operating cash flow per share for the trailing twelve months (TTM) ended in Sep. 2023 was €-0.23.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 33.70% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 56.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Mydecine Innovations Group's Operating Cash Flow per Share or its related term are showing as below:

STU:0NF0' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: 2.9 Med: 48 Max: 67.9
Current: 33.7

During the past 10 years, Mydecine Innovations Group's highest 3-Year average Operating Cash Flow per Share Growth Rate was 67.90% per year. The lowest was 2.90% per year. And the median was 48.00% per year.

STU:0NF0's 3-Year OCF Growth Rate is ranked better than
79.65% of 806 companies
in the Drug Manufacturers industry
Industry Median: 7.45 vs STU:0NF0: 33.70

Mydecine Innovations Group Operating Cash Flow per Share Historical Data

The historical data trend for Mydecine Innovations Group's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mydecine Innovations Group Operating Cash Flow per Share Chart

Mydecine Innovations Group Annual Data

Trend

Dec13

Aug14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Operating Cash Flow per Share

Get a 7-Day Free Trial

-23.92

-2.28

-2.01

-3.55

-0.68

Mydecine Innovations Group Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Operating Cash Flow per Share	Get a 7-Day Free Trial															-0.04	-0.06	-0.11	-0.06	-

Competitive Comparison of Mydecine Innovations Group's Operating Cash Flow per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Mydecine Innovations Group's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Mydecine Innovations Group's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Mydecine Innovations Group's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Mydecine Innovations Group's Price-to-Operating-Cash-Flow falls into.

Mydecine Innovations Group Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Mydecine Innovations Group's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2022 is calculated as

Operating Cash Flow per Share (A: Dec. 2022 )	=	Cash Flow from Operations (A: Dec. 2022 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2022 )
	=	-5.856	/	8.647
	=	-0.68

Mydecine Innovations Group's Operating Cash Flow per Share for the quarter that ended in Dec. 2022 is calculated as

Operating Cash Flow per Share (Q: Sep. 2023 )	=	Cash Flow from Operations (Q: Sep. 2023 )	/	Shares Outstanding (Diluted Average) (Q: Sep. 2023 )
	=	-0.016	/	7.325
	=	-0.00

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.23

Mydecine Innovations Group Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Mydecine Innovations Group's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Mydecine Innovations Group (STU:0NF0) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mydecine Innovations Group Inc (STU:0NF0) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

MYCOF:USA MYIG:UK MYCO:Canada

Address

789 West Pender Street, Suite 810, Vancouver, BC, CAN, V6C 1H2

Website

https://www.mydecine.com

Mydecine Innovations Group Inc is a biopharma and life sciences company engaged in the research, drug development, and clinical trials of psilocybin products.

Mydecine Innovations Group (STU:0NF0) Headlines

No Headlines